Odonate Therapeutics Current Ratio 2016-2019 | ODT

Odonate Therapeutics current ratio from 2016 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Odonate Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.12B $0.02B 5.76
2018-12-31 $0.14B $0.02B 7.68
2018-09-30 $0.16B $0.02B 10.90
2018-06-30 $0.18B $0.01B 17.56
2018-03-31 $0.20B $0.01B 20.50
2017-12-31 $0.20B $0.01B 27.02
2017-09-30 $0.08B $0.00B 22.69
2017-06-30 $0.00B 0.00
2017-03-31 $0.00B 0.00
2016-12-31 $0.00B 0.00
2016-09-30 $0.00B 0.00
2015-12-31 $0.00B $0.00B 7.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.897B $0.000B
Odonate Therapeutics, LLC is a pharmaceutical company. It engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer. Odonate Therapeutics, LLC is based in SAN DIEGO, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.414B 34.76
Astellas Pharma (ALPMY) Japan $28.829B 14.14
Takeda Pharmaceutical (TAK) Japan $27.169B 7.98
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.853B 27.26
Grifols, S.A (GRFS) Spain $15.092B 19.09
Merck (MKGAF) Germany $13.293B 18.14
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Ionis Pharmaceuticals (IONS) United States $9.459B 20.68
Sage Therapeutics (SAGE) United States $9.292B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.044B 0.00
Catalent (CTLT) United States $7.834B 31.44
Jazz Pharmaceuticals (JAZZ) Ireland $7.794B 10.69
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Nektar Therapeutics (NKTR) United States $5.574B 9.09
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.818B 16.93
Tilray (TLRY) Canada $4.302B 0.00
Evotec AG (EVTCY) Germany $4.265B 45.78
FibroGen (FGEN) United States $3.980B 0.00
United Therapeutics (UTHR) United States $3.335B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.191B 11.45
Arrowhead Pharmaceuticals (ARWR) United States $2.704B 407.43
PTC Therapeutics (PTCT) United States $2.503B 0.00
Xencor (XNCR) United States $2.493B 68.05
Zogenix (ZGNX) United States $2.019B 0.00
Portola Pharmaceuticals (PTLA) United States $1.763B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.672B 80.96
Ironwood Pharmaceuticals (IRWD) United States $1.639B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.607B 21.97
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.516B 0.00
USANA Health Sciences (USNA) United States $1.412B 12.27
Corcept Therapeutics (CORT) United States $1.226B 17.49
ArQule (ARQL) United States $1.132B 0.00
Aerie Pharmaceuticals (AERI) United States $1.103B 0.00
Radius Health (RDUS) United States $1.038B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.016B 3.66
Theravance Biopharma (TBPH) Cayman Islands $0.994B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.882B 0.00
Endo (ENDP) Ireland $0.792B 1.27
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.678B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.602B 0.00
Organogenesis Holdings (ORGO) United States $0.584B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.582B 0.00
TherapeuticsMD (TXMD) United States $0.567B 0.00
GlycoMimetics (GLYC) United States $0.535B 0.00
Translate Bio (TBIO) United States $0.495B 0.00
Karyopharm Therapeutics (KPTI) United States $0.480B 0.00
ChemoCentryx (CCXI) United States $0.471B 0.00
Akebia Therapeutics (AKBA) United States $0.462B 0.00
Dermira (DERM) United States $0.460B 0.00
Siga Technologies (SIGA) United States $0.460B 1.08
BioSpecifics Technologies Corp (BSTC) United States $0.455B 22.94
Dova Pharmaceuticals (DOVA) United States $0.452B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.434B 0.00
CV Sciences (CVSI) United States $0.421B 0.00
Flexion Therapeutics (FLXN) United States $0.418B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
Indivior (INVVY) United States $0.415B 1.50
Corbus Pharmaceuticals Holdings (CRBP) United States $0.408B 0.00
CannTrust Holdings (CTST) Canada $0.404B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.396B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.382B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Collegium Pharmaceutical (COLL) United States $0.362B 0.00
Harpoon Therapeutics (HARP) United States $0.346B 0.00
ImmunoGen (IMGN) United States $0.339B 0.00
Xeris Pharmaceuticals (XERS) United States $0.321B 0.00
KalVista Pharmaceuticals (KALV) United States $0.302B 0.00
Rafael Holdings (RFL) United States $0.294B 0.00
OptiNose (OPTN) United States $0.293B 0.00
Molecular Templates (MTEM) United States $0.276B 0.00
Concert Pharmaceuticals (CNCE) United States $0.267B 0.00
Aratana Therapeutics (PETX) United States $0.241B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.238B 0.00
Recro Pharma (REPH) United States $0.224B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.223B 0.00
Lannett Co Inc (LCI) United States $0.219B 2.13
Ocular Therapeutix (OCUL) United States $0.206B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.197B 0.00
Redhill Biopharma (RDHL) Israel $0.181B 0.00
Calithera Biosciences (CALA) United States $0.169B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 54.69
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Ardelyx (ARDX) United States $0.163B 0.00
IMV INC (IMV) Canada $0.161B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.148B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
Jounce Therapeutics (JNCE) United States $0.140B 0.00
Majesco Entertainment (PTE) United States $0.134B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.133B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.126B 0.00
DURECT (DRRX) United States $0.113B 0.00
AgeX Therapeutics (AGE) United States $0.110B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.104B 0.00
Generex Biotechnology (GNBT) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.103B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.093B 0.00
Capnia (SLNO) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Mast Therapeutics (SVRA) United States $0.090B 0.00
Genocea Biosciences (GNCA) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 62.56
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
MediWound (MDWD) Israel $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.084B 0.00
Natural Alternatives (NAII) United States $0.081B 8.07
Cardiome Pharma (CORV) Canada $0.080B 0.00
China SXT Pharmaceuticals (SXTC) China $0.079B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.077B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.075B 0.00
Novan (NOVN) United States $0.072B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Pharmaxis (PXSLY) Australia $0.067B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
India Globalization Capital (IGC) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00